Prophylactic treatment of migraine with botulinum toxin type A: a pharmacoeconomic analysis in a community setting

Figures & data

Table 1. Unit cost of oral triptans (AWP in US$)*.

Drug	Dosage unit	Unit price	Average unit price of drug
Sumatriptan succinate (Imitrex®)	25 mg	21.33	20.37
	50 mg	19.89
	100 mg	19.89
Almotriptan malate (Axert®)	6.25 mg	19.12	19.50
	12.5 mg	19.88
Naratriptan hydrochloride (Amerge®)	1 mg	22.11	22.11
	2.5 mg	22.11
Frovatriptan succinate (Frova®)	2.5 mg	20.17	20.17
Eletriptan hydrobromide (Relpax®)	20 mg	18.32	18.32
	40 mg	18.32
Zolmitriptan (Zomig®)	2.5 mg	18.54	22.69
	5 mg	26.84
Rizatriptan benzoate (Maxalt®)	5 mg	19.69	19.69
	10 mg	19.69
Average unit triptan price			20.41

AWP: average wholesale price

* AWP as per the Redbook 2006.

Figure 1. Total triptan costs for the entire cohort before and after BoNTA treatment. Triptan costs decreased by $ 42,003 after treatment.

Figure 2. Total triptan costs for the 50 CM patients before and after BoNTA treatment. Triptan costs decreased by $ 35,146 in CM patients after treatment.

Figure 3. Office visit costs before and after BoNTA treatment for the entire cohort. BoNTA, botulinum toxin type A.

Figure 4. Mean frequency of migraines/month per patient for the entire cohort before and after BoNTA treatment.

Figure 5. Mean frequency of migraines/month per patient, individuals with chronic migraine.